Quality of life in patients with bullous dermatoses

Clinics in Dermatology

Volumn 30, Issue 1, 2012, Pages 103-107

  Sebaratnam, Deshan F ^a   McMillan, James R ^b   Werth, Victoria P ^c   Murrell, Dédée F ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DISEASE SEVERITY; GENETIC DISORDER; GENODERMATOSIS; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ANXIETY; ATTITUDE TO HEALTH; CAUSALITY; COMORBIDITY; DEPRESSION; HUMANS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, VESICULOBULLOUS; SOCIAL PERCEPTION; STRESS, PSYCHOLOGICAL;

EID: 83155190182     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.03.016     Document Type: Article

References (32)

1. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995, 41:1403-1409. WHOQOL Group.
2. Both H, Essink-Bot M, Busschbach J, et al. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007, 127:2726-2739.
3. Rapp S, Feldman S, Exum M, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999, 41:401-407.
4. Chen S Dermatology quality of life instruments: sorting out the quagmire. J Invest Dermatol 2007, 127:2726-2739.
5. Sampogna F, Picardi A, Melchi C, et al. The impact of skin diseases on patients: comparing dermatologist's opinions with research data collected on patients. Br J Dermatol 2003, 148:989-995.
6. VanBeek M, Beach S, Braslow L, et al. Highlights from the report of the working group on "Core measures of the burden of skin diseases.". J Invest Dermatol 2007, 127:2701-2706.
7. Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003, 56:52-60.
8. Finlay A, Khan G, Luscombe D, et al. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990, 123:751-756.
9. Ware J, Sherbourne C., The MOS 36-item short form health survey (SF-36). Conceptual framework and item selection. Med Care 1992, 30:472-483.
10. Masahiro S, Shigaku I, Yutaka I, Ogawa H An investigation of quality of life (QOL) of pemphigus patients in Japan (First report). J Dermatol 2000, 110:283-288.
11. Terrab Z, Benchikhi H, Maaroufi A, et al. Quality of life and pemphigus. Ann Dermatol Venereol 2005, 132:321-328.
12. Mayrshofer F, Hertl M, Sinkgraven R. Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group. J Dtsch Dermatol Ges 2005, 3:431-435.
13. Finlay A, Khan G Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19:210-216.
14. Tabolli S, Mozzetta A, Antinone V, et al. The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire. Br J Dermatol 2008, 158:1029-1034.
15. Krug S, Scheier I, Cattel R. Handbook for the IPAT Anxiety Scale 1976, Institute for Personality and Ability Testing, Champaign (IL).
16. Krug S, Laughlin J. Handbook for the IPAT Depression Scale 1976, Institute for Personality and Ability Testing, Champaign (IL).
17. Sampogna F, Tabolli S, Soderfeldt B, et al. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006, 154:844-849.
18. Paradisi A, Sampogna F, Di Pietro C, et al. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools. J Am Acad Dermatol 2009, 60:26-29.
19. Goldberg D, Williams P.A user's guide to the General Health Questionnaire 1988, NFER-Nelson, Windsor, UK.
20. Ikeda S, Imamura S, Hashimoto I, et al. History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan. Arch Dermatol Res 2003, 295(Suppl):S12-16.
21. Sampogna F, Chren M, Melchi C, et al. Age, gender, quality of life and psychological distress in patients hospitalised with psoriasis. Br J Dermatol 2006, 154:325-331.
22. Pfütze M, Niedermeier A, Hertl M, et al. Introducing a novel Autoimmune Bullous Skin Disease Intensity Score (ABSIS) in pemphigus. Eur J Dermatol 2007, 17:4-11.
23. Rosenbach M, Murrell DF, Bystryn JC, et al. Reliability and convergent validity of two outcome instruments in pemphigus. J Invest Dermatol 2009, 129:2404-2410.
24. Frew JW, Martin LK, Nijsten T, et al. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br J Dermatol 2009, 161:1323-1330.
25. Venugopal SS, Yan WF, Frew JW, et al. First double-blind randomized clinical trial of intradermal allogeneic fibroblast therapy for severe generalized recessive dystrophic epidermolysis bullosa randomized against placebo injections resulted in similar wound healing that is independent of collagen VII expression. J Investig Dermatol 2010, 130:S67.
26. Horn HM, Tidman MJ Quality of life in epidermolysis bullosa. Clin Exp Dermatol 2002, 27:707-710.
27. Brooks R, Rabin RE, de Charro F. The measurement and validation of health status using EQ-5D: a European perspective 2005, Kluwer Academic, Dordrecht.
28. Ferrario SR, Baiardi P, Zotti AM Update on Family Strain Questionnaire: a tool for the general screening of caregiving-related problems. Qual Life Res 2004, 13:1425-1434.
29. Tabolli S, Sampogna F, Di Pietro C, et al. Quality of life in patients with epidermolysis bullosa. Br J Dermatol 2009, 161:869-877.
30. Scheppingen C, Lettinga AT, Duipmans JC, et al. Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews. Acta Derm Venereol 2008, 88:143-150.
31. Fine JD, Johnson LB, Weiner M, et al. Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa. Clin Exp Dermatol 2004, 29:122-127.
32. Fine JD, Johnson LB, Weiner M, et al. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size. Br J Dermatol 2005, 152:1009-1014.